Literature DB >> 25922518

CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells.

Caroline A Bernhard1, Christine Ried1, Stefan Kochanek2, Thomas Brocker3.   

Abstract

Dendritic cells (DCs) are considered the most potent antigen-presenting cells (APCs), which directly prime or cross-prime MHC I-restricted cytotoxic T cells (CTLs). However, recent evidence suggests the existence of other, as-yet unidentified APCs also able to prime T cells. To identify those APCs, we used adenoviral (rAd) vectors, which do not infect DCs but selectively accumulate in CD169(+) macrophages (MPs). In mice that lack DCs, infection of CD169(+) MPs was sufficient to prime CTLs specific for all epitopes tested. In contrast, CTL responses relying exclusively on cross-presenting DCs were biased to selected strong MHC I-binding peptides only. When both DCs and MPs were absent, no CTL responses could be elicited. Therefore, CD169(+) MPs can be considered APCs that significantly contribute to CTL responses.

Entities:  

Keywords:  CD169+ macrophage; CD8 T cell; adenovirus; cross-presentation; dendritic cell

Mesh:

Substances:

Year:  2015        PMID: 25922518      PMCID: PMC4418891          DOI: 10.1073/pnas.1423356112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Marginal zone macrophages and immune responses against viruses.

Authors:  Stephan Oehen; Bernhard Odermatt; Urs Karrer; Hans Hengartner; Rolf Zinkernagel; Constantino López-Macías
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

2.  Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo.

Authors:  C Kurts; M Cannarile; I Klebba; T Brocker
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

Review 3.  Defining dendritic cells by conditional and constitutive cell ablation.

Authors:  Liat Bar-On; Steffen Jung
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

4.  Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells.

Authors:  H C Probst; K Tschannen; B Odermatt; R Schwendener; R M Zinkernagel; M Van Den Broek
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

5.  Parenchymal cells critically curtail cytotoxic T-cell responses by inducing Bim-mediated apoptosis.

Authors:  Anton Gruber; Michael A Cannarile; Cedric Cheminay; Christine Ried; Peggy Marconi; Georg Häcker; Thomas Brocker
Journal:  Eur J Immunol       Date:  2010-04       Impact factor: 5.532

Review 6.  Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming?

Authors:  Cornelis J M Melief
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

7.  Dynamics of T cell, antigen-presenting cell, and pathogen interactions during recall responses in the lymph node.

Authors:  Tatyana Chtanova; Seong-Ji Han; Marie Schaeffer; Giel G van Dooren; Paul Herzmark; Boris Striepen; Ellen A Robey
Journal:  Immunity       Date:  2009-08-21       Impact factor: 31.745

8.  Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.

Authors:  G B Lipford; M Hoffman; H Wagner; K Heeg
Journal:  J Immunol       Date:  1993-02-15       Impact factor: 5.422

9.  Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection.

Authors:  Nicole Torti; Senta M Walton; Thomas Brocker; Thomas Rülicke; Annette Oxenius
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

10.  Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage.

Authors:  Matthew M Meredith; Kang Liu; Guillaume Darrasse-Jeze; Alice O Kamphorst; Heidi A Schreiber; Pierre Guermonprez; Juliana Idoyaga; Cheolho Cheong; Kai-Hui Yao; Rachel E Niec; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2012-05-21       Impact factor: 14.307

View more
  48 in total

1.  Targeted Delivery of Antigen to Activated CD169+ Macrophages Induces Bias for Expansion of CD8+ T Cells.

Authors:  Landon J Edgar; Norihito Kawasaki; Corwin M Nycholat; James C Paulson
Journal:  Cell Chem Biol       Date:  2018-11-01       Impact factor: 8.116

2.  CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells.

Authors:  Farah Bou Nasser Eddine; Greta Forlani; Letizia Lombardo; Alessandra Tedeschi; Giovanna Tosi; Roberto S Accolla
Journal:  Oncoimmunology       Date:  2016-11-28       Impact factor: 8.110

3.  Unexpected Role of CD8 T Cells in Accelerated Clearance of Salmonella enterica Serovar Typhimurium from H-2 Congenic mice.

Authors:  Jasmine C Labuda; Claire E Depew; Oanh H Pham; Joseph M Benoun; Nora A Ramirez; Stephen J McSorley
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 4.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

5.  PD-L1 expression in regional lymph nodes and predictable roles in anti-cancer immune responses.

Authors:  Yoshihiro Komohara; Mamoru Harada; Koji Ohnishi; Keiichiro Kumamoto; Toshiyuki Nakayama
Journal:  J Clin Exp Hematop       Date:  2020-07-08

Review 6.  Developing T-cell therapies for lymphoma without receptor engineering.

Authors:  Melanie Grant; Catherine M Bollard
Journal:  Blood Adv       Date:  2017-12-08

7.  Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus Infection.

Authors:  Zachariah P Tritz; Robin C Orozco; Courtney S Malo; Katayoun Ayasoufi; Cori E Fain; Roman H Khadka; Emma N Goddery; Lila T Yokanovich; Megan L Settell; Michael J Hansen; Fang Jin; Kevin D Pavelko; Larry R Pease; Aaron J Johnson
Journal:  J Immunol       Date:  2020-07-31       Impact factor: 5.422

8.  Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.

Authors:  Claudine Graf; Petra Wilgenbus; Sven Pagel; Jennifer Pott; Federico Marini; Sabine Reyda; Maki Kitano; Stephan Macher-Göppinger; Hartmut Weiler; Wolfram Ruf
Journal:  Sci Immunol       Date:  2019-09-20

9.  CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients.

Authors:  Jiali Zhang; Jing Xu; Rong-Xin Zhang; Yi Zhang; Qing-Jian Ou; Jin-Qing Li; Ze-Zhou Jiang; Xiao-Jun Wu; Yu-Jing Fang; Limin Zheng
Journal:  Oncoimmunology       Date:  2016-04-29       Impact factor: 8.110

10.  Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs.

Authors:  Joao N Duarte; Juan J Cragnolini; Lee Kim Swee; Angelina M Bilate; Justin Bader; Jessica R Ingram; Ali Rashidfarrokhi; Tao Fang; Ariën Schiepers; Leo Hanke; Hidde L Ploegh
Journal:  J Immunol       Date:  2016-11-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.